MUMBAI |
Fri Nov 23, 2012 1:02am EST
MUMBAI (Reuters) – Ranbaxy Laboratories, India’s tip drugmaker by sales, pronounced it has removed a cholesterol obscure drug atorvastatin from a United States.
The remember will temporarily interrupt reserve of a general Lipitor to a U.S., Ranbaxy, a section of Japan’s Daiichi Sankyo Co, pronounced in a statement.
The review in this courtesy is approaching to be finished within dual weeks, after that a association expects to resume supplies, it said.
Ranbaxy shares extended waste and were down 1.87 percent by 0553 GMT.
(Reporting by Kaustubh Kulkarni)